COMMUNIQUÉS West-GlobeNewswire

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
02/07/2025
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second [...]
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
02/07/2025
Cash resources totaled approximately $225 million as of June 30, 2025 CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric [...]
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
02/07/2025
Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study BriaCell’s Phase 3 study currently has 58 active [...]
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
02/07/2025
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat [...]
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
02/07/2025
Name change reflects company’s leadership position with its cryptocurrency treasury reserve strategy focused on the HYPE token Company to commence trading on Nasdaq under the symbol “HYPD” effective July 3rd Also [...]
PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine
02/07/2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on the development and commercialization of [...]
Middlesex Recovery Unveils Brand Refresh to Reflect Unified Identity with BayMark Health Services
02/07/2025
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Middlesex Recovery, a provider of office-based opioid treatment for substance use disorders, has introduced a brand refresh that reflects its alignment with BayMark [...]
AppleGate Recovery Unveils Brand Refresh Aligned with BayMark Health Services Continuum of Care
02/07/2025
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- AppleGate Recovery, a leading provider of office-based medication-assisted treatment (MAT) for substance use disorders, is proud to announce the launch of its [...]
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
02/07/2025
Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact, peer-reviewed [...]
Extendicare Acquires Closing the Gap Healthcare Group
02/07/2025
Extendicare increases Senior Secured Credit Facility to $375 million MARKHAM, Ontario, July 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned [...]
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
02/07/2025
PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods ® IBS inFoods ® IBS provides [...]
Highest THCa Flower July 2025: New Hemp Hop Strains Hit the Market
02/07/2025
CHARLOTTE, N.C., July 02, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has announced the launch of 2 new high-THCa strains - London Jealousy and Gravel Pit . As demand for the best exotic THCa flower continues to grow, Hemp Hop [...]
AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions
02/07/2025
Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent [...]
Cronos Grows its International Footprint in Switzerland
02/07/2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS ® medical cannabis brand in [...]
SurgiBox Expands European Presence Through Strategic Partnership with Ondatec Medical in Türkiye
02/07/2025
CAMBRIDGE, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- SurgiBox, Inc., a pioneering medical technology company dedicated to bringing safe surgery to every patient, today announced a strategic partnership with Ondatec [...]
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
02/07/2025
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the [...]
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
02/07/2025
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With [...]
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
02/07/2025
1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, [...]
Cyclacel Pharmaceuticals Announces Stock Split
02/07/2025
BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today [...]

Pages